Our main approach to identify cancer-related genes was to filter for the most frequent aberrations but we noted that well characterised cancer driver genes, such as CCNE1 and ERBB2[7], were not identified since they were amplified in less than 40% of tumours. This evidence concerns the gene ERBB2 and cancer.